| Authors: |
Henze L; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany., Braun J; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany., Meyer-Arndt L; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Jürchott K; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany., Schlotz M; Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Michel J; Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany., Grossegesse M; Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany., Mangold M; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany., Dingeldey M; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany., Kruse B; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany., Holenya P; JPT Peptide Technologies GmbH, Berlin, Germany., Mages N; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany.; Max Planck Institute for Molecular Genetics, Berlin, Germany., Reimer U; JPT Peptide Technologies GmbH, Berlin, Germany., Eckey M; JPT Peptide Technologies GmbH, Berlin, Germany., Schnatbaum K; JPT Peptide Technologies GmbH, Berlin, Germany., Wenschuh H; JPT Peptide Technologies GmbH, Berlin, Germany., Timmermann B; Max Planck Institute for Molecular Genetics, Berlin, Germany., Klein F; Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; German Center for Infection Research (DZIF), Partner site Bonn-Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Nitsche A; Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany., Giesecke-Thiel C; Max Planck Institute for Molecular Genetics, Berlin, Germany., Loyal L; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany., Thiel A; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany. |
